한글목차

세포 및 유전자 치료 시장 규모는 최근 비약적으로 확대하고 있습니다. 2025년 213억 3,000만 달러에서 2026년에는 262억 1,000만 달러로, CAGR 22.9%로 성장할 것으로 예상됩니다. 지금까지의 성장 요인으로는 세포 및 유전자 치료의 제한된 가용성, 기존 치료법에 대한 의존도, 초기 세대 치료법의 높은 비용, 종양학 및 신경 질환의 발생률 증가, 전문 치료 센터의 부족 등을 꼽을 수 있습니다.

세포 및 유전자 치료 시장 규모는 향후 몇 년간 급격한 성장이 전망됩니다. 2030년에는 605억 8,000만 달러에 달하고, CAGR은 23.3%가 될 전망입니다. 예측 기간 동안 성장 요인으로는 첨단 CAR-T 치료제 및 유전체 편집 치료제 개발, 임상시험 및 연구 프로그램 확대, 맞춤형 의료 도입 증가, 희귀 질환 치료에 대한 정부 지원 및 자금 지원 증가, 치료 모니터링 및 환자 관리를 위한 디지털 플랫폼의 통합 등이 있습니다. 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 CAR-T 및 줄기세포 치료의 도입 확대, 종양학 및 희귀질환 유전자 치료에 대한 투자 증가, 맞춤형 및 표적 세포 치료의 성장, 첨단 치료법을 제공하는 병원 및 외래 수술 센터의 확대, 임상 현장에서의 유전체 편집 기술 및 바이러스 벡터 기반 기술의 통합을 들 수 있습니다.

진행 중인 임상시험의 증가는 향후 세포 및 유전자 치료 시장의 성장을 촉진할 것으로 예상됩니다. 임상시험은 새로운 의료 치료, 중재 또는 진단 절차의 안전성과 유효성을 평가하기 위해 인간 피험자를 대상으로 실시하는 연구입니다. 임상시험은 세포 및 유전자 치료제의 개발 및 발전에 있어 매우 중요한 역할을 합니다. 새로운 치료법을 시험하고 그 안전성과 효과에 대한 데이터를 수집할 수 있는 안전하고 통제된 환경을 제공합니다. 예를 들어, 영국제약산업협회(ABPI)의 발표에 따르면, 2024년 12월 기준 영국 제약 업계의 임상시험 개시 건수는 2년 연속 증가하여 2022년 411건에서 2023년 426건으로 늘어났다고 합니다. 따라서 진행 중인 임상시험의 증가가 세포 및 유전자 치료 시장의 성장을 견인하고 있습니다.

세포 및 유전자 치료 시장에서 사업을 전개하는 주요 기업들은 시장에서의 경쟁 우위를 확보하기 위해 아그노스틱 시스템 도입에 집중하고 있습니다. 아그노스틱 시스템은 다양한 세포-유전자 치료(CGT) 소프트웨어 플랫폼 및 바이오의약품 및 공급업체를 위한 플랫폼과 통합된 시스템을 말합니다. 예를 들어, 2023년 4월 미국 헬스케어 기업 아메리소스버겐(AmerisourceBergen)은 세포-유전자 치료(CGT) 치료 프로세스 전반의 연계 강화와 환자 및 의료 제공자 경험 향상을 위한 새로운 플랫폼 독립형 시스템인 '세포-유전자 치료 통합 허브'를 출범했습니다. 이 허브는 회사의 고객관계관리 시스템을 기반으로 하며, 혜택 조사 프로세스 가속화, 치료 개발 및 운송 상황의 실시간 가시화, 환자 지원 조정 지원을 목적으로 설계되었습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별, 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Gene therapy involves the transmission of genetic material, typically in the form of a carrier or vector, and the uptake of the gene into the proper body cells. Cell therapy includes introducing cells into the patient with the appropriate function. Some procedures combine cell therapy with gene therapy.

The main types of products in cell and gene therapies are cell therapy and gene therapy. Gene therapy is a branch of medicine that focuses on modifying the genetic material of cells to achieve a therapeutic effect or to heal disease by repairing or reconstructing damaged genetic material. The different applications include oncology, dermatology, musculoskeletal, and others and involve various sectors such as hospitals, ambulatory surgical centers, cancer care centers, wound care centers, and others.

Tariffs have impacted the cell and gene therapy market by raising the cost of imported viral vectors, laboratory reagents, and specialized delivery equipment. Segments like CAR-T cell therapy and viral vector-based gene therapy are most affected, with North America, Europe, and Asia-Pacific regions like China and India facing significant import duties. This has increased operational costs and slowed therapy deployment. On the positive side, tariffs have encouraged local manufacturing, investment in domestic R&D, and innovation in cost-effective therapy delivery systems.

The cell and gene therapy market research report is one of a series of new reports from The Business Research Company that provides cell and gene therapy market statistics, including cell and gene therapy industry global market size, regional shares, competitors with a cell and gene therapy market share, detailed cell and gene therapy market segments, market trends and opportunities, and any further data you may need to thrive in the cell and gene therapy industry. This cell and gene therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell and gene therapy market size has grown exponentially in recent years. It will grow from $21.33 billion in 2025 to $26.21 billion in 2026 at a compound annual growth rate (CAGR) of 22.9%. The growth in the historic period can be attributed to limited availability of cell and gene therapies, reliance on conventional treatment modalities, high cost of early-generation therapies, growing incidence of oncology and neurological disorders, lack of specialized treatment centers.

The cell and gene therapy market size is expected to see exponential growth in the next few years. It will grow to $60.58 billion in 2030 at a compound annual growth rate (CAGR) of 23.3%. The growth in the forecast period can be attributed to development of advanced car-t and genome editing therapies, expansion of clinical trials and research programs, increasing adoption of personalized medicine, rising government support and funding for rare disease treatments, integration of digital platforms for therapy monitoring and patient management. Major trends in the forecast period include increasing adoption of car-t and stem cell therapies, rising investment in gene therapy for oncology and rare diseases, growth in personalized and targeted cell-based treatments, expansion of hospital and ambulatory surgical centers offering advanced therapies, integration of genome editing and viral vector-based technologies in clinical practice.

A growing number of ongoing clinical trials is expected to propel the growth of the cell and gene therapy market going forward. Clinical trials are research studies conducted with human participants to evaluate the safety and effectiveness of new medical treatments, interventions, or diagnostic procedures. Clinical trials play a vital role in the development and advancement of cell and gene therapy. They provide a safe and controlled environment to test new therapies and collect data on their safety and efficacy. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, highlighted that the number of pharmaceutical industry trials launched in the UK increased for the second consecutive year, rising from 411 in 2022 to 426 in 2023. Therefore, a growing number of ongoing clinical trials is driving the growth of the cell and gene therapy market.

Major companies operating in the cell and gene therapy market are increasing their focus on introducing agnostic systems to gain a competitive edge in the market. Agnostic systems refer to systems that are integrated with a variety of different cell and gene therapy (CGT) software platforms, as well as biopharmaceutical or provider-facing platforms. For instance, in April 2023, AmerisourceBergen, a US-based healthcare company, launched the Cell and Gene Therapy Integration Hub, a new platform-agnostic system that aims to improve connectivity across the cell and gene therapy (CGT) treatment journey to enable an enhanced patient and provider experience. The hub is powered by the company's customer relationship management system and is designed to speed up the benefits investigation process, give a real-time view of therapy development and transportation status, and assist in coordinating patient support.

In January 2024, Kyowa Kirin Co., Ltd., a Japan-based pharmaceutical company that develops and sells drugs to improve human health and well-being worldwide, acquired Orchard Therapeutics for an undisclosed amount. With this acquisition, Kyowa Kirin Co. Ltd. aims to enhance its capabilities in developing innovative gene therapies for rare diseases, expanding its therapeutic portfolio, and addressing unmet medical needs. Orchard Therapeutics plc is a UK-based biotech company that specializes in developing innovative cell and gene therapies.

Major companies operating in the cell and gene therapy market are Biogen Inc., Novartis AG, Gilead Sciences, Ionis Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., ArrowHead Pharmaceuticals Inc., Spark Therapeutics, Bluebird Bio Inc., RegenexBio, Mesoblast Limited, Stempeutics Research Pvt. Ltd., EdiGene Inc., Takara Bio, Oxford Biomedica plc, Merck, GenScript, Cellular Biomedicine Group, inStem, Bristol-Myers Squibb, Amgen, Pfizer, Kite Pharma, Freeline Therapeutics, PsiOxus Therapeutics, Herantis Pharma Plc, AstraZeneca

North America was the largest region in the cell and gene therapy market in 2025. The regions covered in the cell and gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell and gene therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell and gene therapy market includes revenues earned by entities treating cancer, cystic fibrosis, heart disease, diabetes, hemophilia, and AIDS. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell and Gene Therapy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cell and gene therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell and gene therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell and gene therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Cell Therapy; Gene Therapy
• 2) By Application: Oncology; Neurological Disorders; Other Applications
• 3) By End User: Hospitals; Ambulatory Surgical Centers; Cancer Care Centers; Wound Care Centers; Other End-Users
• Subsegments:
• 1) By Cell Therapy: Autologous Cell Therapy; Allogeneic Cell Therapy; Stem Cell Therapy; CAR-T Cell Therapy
• 2) By Gene Therapy: Viral Vector-Based Gene Therapy; Non-Viral Vector-Based Gene Therapy; Genome Editing Technologies; Antisense Oligonucleotide Therapy
• Companies Mentioned: Biogen Inc.; Novartis AG; Gilead Sciences; Ionis Pharmaceuticals Inc.; Alnylam Pharmaceuticals Inc.; ArrowHead Pharmaceuticals Inc.; Spark Therapeutics; Bluebird Bio Inc.; RegenexBio; Mesoblast Limited; Stempeutics Research Pvt. Ltd.; EdiGene Inc.; Takara Bio; Oxford Biomedica plc; Merck; GenScript; Cellular Biomedicine Group; inStem; Bristol-Myers Squibb; Amgen; Pfizer; Kite Pharma; Freeline Therapeutics; PsiOxus Therapeutics; Herantis Pharma Plc; AstraZeneca
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Cell and Gene Therapy Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Cell and Gene Therapy Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Cell and Gene Therapy Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Cell and Gene Therapy Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Car-T And Stem Cell Therapies
  • 4.2.2 Rising Investment In Gene Therapy For Oncology And Rare Diseases
  • 4.2.3 Growth In Personalized And Targeted Cell-Based Treatments
  • 4.2.4 Expansion Of Hospital And Ambulatory Surgical Centers Offering Advanced Therapies
  • 4.2.5 Integration Of Genome Editing And Viral Vector-Based Technologies In Clinical Practice

5. Cell and Gene Therapy Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Ambulatory Surgical Centers
• 5.3 Cancer Care Centers
• 5.4 Wound Care Centers
• 5.5 Specialty Research & Treatment Institutes

6. Cell and Gene Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cell and Gene Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Cell and Gene Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Cell and Gene Therapy Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Cell and Gene Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Cell and Gene Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cell and Gene Therapy Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cell and Gene Therapy Market Segmentation

• 9.1. Global Cell and Gene Therapy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cell Therapy, Gene Therapy
• 9.2. Global Cell and Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oncology, Neurological Disorders, Other Applications
• 9.3. Global Cell and Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users
• 9.4. Global Cell and Gene Therapy Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy, CAR-T Cell Therapy
• 9.5. Global Cell and Gene Therapy Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, Genome Editing Technologies, Antisense Oligonucleotide Therapy

10. Cell and Gene Therapy Market Regional And Country Analysis

• 10.1. Global Cell and Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Cell and Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cell and Gene Therapy Market

• 11.1. Asia-Pacific Cell and Gene Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cell and Gene Therapy Market

• 12.1. China Cell and Gene Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cell and Gene Therapy Market

• 13.1. India Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cell and Gene Therapy Market

• 14.1. Japan Cell and Gene Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cell and Gene Therapy Market

• 15.1. Australia Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cell and Gene Therapy Market

• 16.1. Indonesia Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cell and Gene Therapy Market

• 17.1. South Korea Cell and Gene Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cell and Gene Therapy Market

• 18.1. Taiwan Cell and Gene Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cell and Gene Therapy Market

• 19.1. South East Asia Cell and Gene Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cell and Gene Therapy Market

• 20.1. Western Europe Cell and Gene Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cell and Gene Therapy Market

• 21.1. UK Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cell and Gene Therapy Market

• 22.1. Germany Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cell and Gene Therapy Market

• 23.1. France Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cell and Gene Therapy Market

• 24.1. Italy Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cell and Gene Therapy Market

• 25.1. Spain Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cell and Gene Therapy Market

• 26.1. Eastern Europe Cell and Gene Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cell and Gene Therapy Market

• 27.1. Russia Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cell and Gene Therapy Market

• 28.1. North America Cell and Gene Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cell and Gene Therapy Market

• 29.1. USA Cell and Gene Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cell and Gene Therapy Market

• 30.1. Canada Cell and Gene Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cell and Gene Therapy Market

• 31.1. South America Cell and Gene Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cell and Gene Therapy Market

• 32.1. Brazil Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cell and Gene Therapy Market

• 33.1. Middle East Cell and Gene Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cell and Gene Therapy Market

• 34.1. Africa Cell and Gene Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Cell and Gene Therapy Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cell and Gene Therapy Market Regulatory and Investment Landscape

36. Cell and Gene Therapy Market Competitive Landscape And Company Profiles

• 36.1. Cell and Gene Therapy Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Cell and Gene Therapy Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Cell and Gene Therapy Market Company Profiles
  • 36.3.1. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Gilead Sciences Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Ionis Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Alnylam Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Cell and Gene Therapy Market Other Major And Innovative Companies

• ArrowHead Pharmaceuticals Inc., Spark Therapeutics, Bluebird Bio Inc., RegenexBio, Mesoblast Limited, Stempeutics Research Pvt. Ltd., EdiGene Inc., Takara Bio, Oxford Biomedica plc, Merck, GenScript, Cellular Biomedicine Group, inStem, Bristol-Myers Squibb, Amgen

38. Global Cell and Gene Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cell and Gene Therapy Market

40. Cell and Gene Therapy Market High Potential Countries, Segments and Strategies

• 40.1 Cell and Gene Therapy Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Cell and Gene Therapy Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Cell and Gene Therapy Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer